Format : Videos + Pdf
Release Year : 2025
Program Overview
The Scripps San Diego Genitourinary Annual Course in Oncology (GUACO) is a comprehensive educational program focused on the diagnosis, treatment, and multidisciplinary management of genitourinary (GU) cancers. This CME-accredited course delivers expert-led, evidence-based updates designed to support clinical decision-making across the continuum of GU oncology care.
The program addresses prostate, bladder, kidney, and related GU malignancies, emphasizing emerging therapies, clinical trial data, and real-world application through case-based learning.
Educational Objectives
Upon completion of this educational activity, participants will be able to:
-
Summarize the current landscape of prostate, bladder, and kidney cancers, including epidemiology, diagnostic advances, treatment strategies, and ongoing challenges in patient management.
-
Evaluate current best practices and emerging approaches for managing localized and advanced genitourinary malignancies, with a focus on evidence-based standards and innovation in GU cancer care.
-
Develop structured clinical approaches for the optimal use of available treatment modalities in the management of GU malignancies.
-
Integrate multidisciplinary collaboration and shared decision-making into complex patient care, promoting coordinated treatment strategies and improved clinical outcomes.
Who Should Attend
This program is designed for healthcare professionals involved in the care of patients with genitourinary cancers, including:
-
Medical oncologists and hematologists
-
Urologists and surgical oncologists
-
Radiation oncologists
-
Advanced practice providers (nurse practitioners, physician assistants, and clinical nurse specialists)
-
Residents and fellows in oncology, urology, or radiation oncology
-
Oncology nurses and pharmacists supporting GU cancer treatment and survivorship care
What You Will Learn
Participants will gain practical and up-to-date knowledge in the following areas:
-
Recent clinical trial results and regulatory developments in GU oncology
-
Advances in systemic therapies, including immunotherapy, targeted therapy, and hormonal treatments for prostate and bladder cancer
-
Surgical and radiation therapy innovations, including minimally invasive and focal treatment approaches
-
Multidisciplinary case discussions highlighting diagnostic and therapeutic challenges
-
Survivorship planning and supportive care strategies tailored to patients with GU malignancies
Program Topics
Prostate Cancer
-
Screening and early detection strategies
-
Management of oligometastatic and castration-resistant disease
-
Theranostics and emerging treatment approaches
-
Case-based clinical decision-making
Bladder Cancer
-
Management of non–muscle-invasive disease
-
Role of radiotherapy and surgical interventions
-
Systemic therapies, including immunotherapy and antibody-drug conjugates
-
Multidisciplinary case reviews
Kidney Cancer
-
Treatment approaches for small renal masses
-
Role of cytoreductive nephrectomy
-
Renal cell carcinoma subtyping
-
Hereditary kidney cancer guidelines and management
-
Case-based discussions
Learning Format
-
Expert-led educational sessions
-
Multidisciplinary panels and case discussions
-
Clinically focused content applicable to daily practice